Title:
プテリジノン誘導体のＥＧＦＲ阻害剤としての使用
Document Type and Number:
Japanese Patent JP7320823
Kind Code:
B2
Abstract:
The present invention relates to a pteridinone derivative serving as an EGFR inhibitor and use thereof. Specifically, the present invention relates to a compound represented by the following formula I, pharmaceutical composition comprising the compound of the following formula I, and use of the compound in preparation of drugs for treating EGFR-mediated diseases or inhibiting EGFR.
Inventors:
Lee, Hong Lin
Sue, you fan
Tsao, Zenjang
Tso, Way
Sue, Yuchun
Swan, Dehen
One, shea
Chen, Zou
Sue, you fan
Tsao, Zenjang
Tso, Way
Sue, Yuchun
Swan, Dehen
One, shea
Chen, Zou
Application Number:
JP2018513714A
Publication Date:
August 04, 2023
Filing Date:
May 30, 2016
Export Citation:
Assignee:
Shanghai Yidien Pharmaceutical Technology Development Company, Limited
International Classes:
C07D475/00; A61K31/519; A61P35/00; A61P35/02; A61P43/00
Domestic Patent References:
| JP2003509425A | ||||
| JP2008504281A |
Foreign References:
| US20150126508 | ||||
| US20140296216 | ||||
| CN103012399A |
Other References:
Wei Zhou ほか9名、Journal of Medicinal Chemistry、2013年、56、p.7821~7837
Attorney, Agent or Firm:
Kiyoshi Kuzuwa
Previous Patent: System and Peripherals
Next Patent: ELECTRIC CONNECTOR AND ITS METHOD OF APPLICATION
Next Patent: ELECTRIC CONNECTOR AND ITS METHOD OF APPLICATION